Dymicron Bets Big on Diamond Material for Total Disc Replacement

Dymicron Triadyme Cervical Disc

When Dymicron received FDA Investigational Device Exemption (IDE) approval to launch a pivotal trial of its Triadyme-C cervical artificial disc in July, the company took an important step toward entering the competitive U.S. spine market.

Dymicron was founded in 1997 with the goal of developing a next-generation cervical total disc...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

DL

Darcy Lewis Darcy Lewis is an ORTHOWORLD Contributing Editor



Contact Us

0